This is the first renewal application for a K24 award for Dr. Howard Rosen, a behavioral neurologist at the University of California, San Francisco. Dr. Rosen?s research focuses on early recognition and longitudinal tracking of atypical neurodegenerative diseases, in particular frontotemporal dementia (FTD). The work takes place at the UCSF Memory and Aging Center, a large multidisciplinary group dedicated to research, care and education in neurodegenerative diseases. In the first cycle of this project, Dr. Rosen served as a mentor for 21 individuals at various stages of training and accomplished his goals of expanding his research on familial forms of FTD. He helped to implement new strategies for diagnosis of FTD through collaboration with the UCSF Department of Psychiatry. Dr. Rosen also expanded the reach of his educational expertise by leading development of the educational curriculum for a new training program called the Global Brain Health Institute, the mission of which is to address worldwide threats to brain health through training of professionals from a variety of disciplines. With continued K24 funding, Dr. Rosen will continue his leadership of research and training at the MAC, focusing on improving methods for measuring change in FTD for use in clinical trials and expanding collaboration with UCSF Psychiatry. He will improve his expertise as an investigator through selective coursework and collaboration with expert colleagues at UCSF.
This project would support continued funding for Dr. Howard Rosen, a behavioral neurologist in the Department of Neurology at the University of California, San Francisco. Dr. Rosen conducts patient-oriented research on early and accurate diagnosis and longitudinal tracking of diseases that cause dementia, in particular frontotemporal dementia. He is a committed teacher and funds from this project will allow him to continue mentoring young trainees whose goals is to pursue research in neurodegenerative disease.
|Ljubenkov, Peter A; Staffaroni, Adam M; Rojas, Julio C et al. (2018) Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol 5:1250-1263|
|Yokoyama, Jennifer S; Karch, Celeste M; Fan, Chun C et al. (2017) Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol 133:825-837|
|Spina, Salvatore; Schonhaut, Daniel R; Boeve, Bradley F et al. (2017) Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology 88:758-766|
|Perry, David C; Datta, Samir; Sturm, Virginia E et al. (2017) Reward deficits in behavioural variant frontotemporal dementia include insensitivity to negative stimuli. Brain 140:3346-3356|
|Boise, Linda; Hinton, Ladson; Rosen, Howard J et al. (2017) Will My Soul Go to Heaven If They Take My Brain? Beliefs and Worries About Brain Donation Among Four Ethnic Groups. Gerontologist 57:719-734|
|Brown, Jesse A; Hua, Alice Y; Trujllo, Andrew et al. (2017) Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy. Neuroimage Clin 16:564-574|
|Desikan, Rahul S; Fan, Chun Chieh; Wang, Yunpeng et al. (2017) Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score. PLoS Med 14:e1002258|
|Chen, Jason; Yu, Jin-Tai; Wojta, Kevin et al. (2017) Genome-wide association study identifies MAPT locus influencing human plasma tau levels. Neurology 88:669-676|
|Elahi, Fanny M; Marx, Gabe; Cobigo, Yann et al. (2017) Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease. Neuroimage Clin 16:595-603|
|Sturm, Virginia E; Perry, David C; Wood, Kristie et al. (2017) Prosocial deficits in behavioral variant frontotemporal dementia relate to reward network atrophy. Brain Behav 7:e00807|
Showing the most recent 10 out of 51 publications